Therapeutic Advances in Endocrinology and Metabolism Q1 Unclaimed
Therapeutic Advances in Endocrinology and Metabolism is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 44. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on endocrinology, metabolism, metabolic diseases, diabetes. It has an SJR impact factor of 1,301 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,301.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1800 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,301
SJR Impact factor44
H Index39
Total Docs (Last Year)176
Total Docs (3 years)2630
Total Refs754
Total Cites (3 years)168
Citable Docs (3 years)4.04
Cites/Doc (2 years)67.44
Ref/DocOther journals with similar parameters
Endocrine Reviews Q1
Nature Reviews Endocrinology Q1
Nature Metabolism Q1
Diabetes Care Q1
Bone Research Q1
Compare this journals
Aims and Scope
Best articles by citations
Review: Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
View moreReview: Endocrine and metabolic emergencies: thyroid storm
View moreEffect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes
View moreBrugada ECG pattern during hyperkalemic diabetic ketoacidosis
View moreTraditional clinical criteria outperform high-sensitivity C-reactive protein for the screening of hepatic nuclear factor 1 alpha maturity-onset diabetes of the young among young Asians with diabetes
View moreTreating low high-density lipoprotein cholesterol: what is the evidence?
View moreThe road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
View moreReaction to the recent publication by Rosemary Basson entitled 'Testosterone therapy for reduced libido in women'
View moreSapropterin hydrochloride: enzyme enhancement therapy for phenylketonuria
View moreEfficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes
View moreTreating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety
View moreVisfatin level in children and adolescents with autoimmune thyroiditis
View moreRecurrent Graves' hyperthyroidism after prolonged radioiodine-induced hypothyroidism
View moreComparison of conventional risk factors in middle-aged versus elderly diabetic and nondiabetic patients with myocardial infarction: prediction with decision-analytic model
View moreExpression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET
View moreThe effects of omega-3 plus vitamin E and zinc plus vitamin C supplementation on cardiovascular risk markers in postmenopausal women with type 2 diabetes
View moreGlycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
View morePrevention of type 1 diabetes mellitus using a novel vaccine
View moreLow skeletal muscle mass is associated with the risk of all-cause mortality in patients with type 2 diabetes mellitus
View moreSafety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors
View moreEffect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
View morePatient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases
View moreThe effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
View moreEvidence for statin therapy in polycystic ovary syndrome
View more
Comments